NEWS @ IMMUNOSCIENCE

  • September 2011 - ImmunoScience welcomes Dr. Luc Montagnier to its Scientific Advisory Board.
  • November 2011 - ImmunoScience completes construction of its BSL-3 research facility in Dublin, CA.
  • June 2012 - ImmunoScience completes construction of its BSL-2 research facility in Dublin, CA.
  • July 2012 - ImmunoScience presented an exhibit at AIDS 2012 International AIDS Conference in Washington D.C.
  • January 2013 - ImmunoScience successfully completes animal studies at UC Davis, CA.
  • March 2013 - ImmunoScience reaches GMP milestone at its facilities in Dublin, CA.
  • June 2013 - ImmunoScience partners with Joint Clinical Research Center (JCRC) in Uganda to conduct Phase I Clinical trials for its therapeutic HIV vaccine.
  • October 2013 - ImmunoScience concludes audit by Uganda National Drug Authority at its facilities in California in expectation of Phase I Clinical trials.
  • November 2014 - ImmunoScience successfully completes a second Macaque (monkey) study of SIV infected animals at CA Primate Research Center.
  • June 2015 - ImmunoScience successfully completes a study in humanized mice.
  • January 2016 - ImmunoScience applies for approval for Phase I trials in South Africa.
  • June 2016 - ImmunoScience gets conditional green light for a trial in South Africa once a trial in UK is initiated.
  • September 2016 - Scientists at Guys Hospital London agree to conduct Phase I trial for ImmunoScience in the UK.
  • January 2017 - ImmunoScience applies for clinical trials in the UK to regulatory bodies.
  • August 2016 - ImmunoScience scientists publish two papers in peer reviewed journals.
  • April 2017 - ImmunoScience receives letter from UK authorities regarding requirements for additional audit and documentation.